Genomic and protein alterations in 126 triple-negative (TN) metaplastic breast cancers | Caris Life Sciences
Home / Research / Publications / Genomic and protein alterations in 126 triple-negative (TN) metaplastic breast cancers

Publications

Genomic and protein alterations in 126 triple-negative (TN) metaplastic breast cancers

Similar to other tumor types, prostate cancer is becoming molecularly stratified to identify targeted
status (overexpressed, ARv7), however new molecular pathways are being determined as having a
major role in prostate molecular pathogenesis, with potential treatment impact.

Download Publication
Learn More
Name(Required)